Skip to main content

Table 3 The association between miR-30c-5p expression and MACE incidence in subjects with ACS

From: Downregulation of serum miR-30c-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients

Variables

Low miR-30c-5p expression (n = 50)

High miR-30c-5p expression (n = 48)

P-value

Total MACE

25 (50.00%)

13 (27.08%)

0.020*

Death

4 (8.00%)

2 (4.17%)

0.429

Angina

7 (14.00%)

4 (8.33%)

0.374

Revascularization

5 (10.00%)

3 (6.25%)

0.498

Reinfarction

3 (6.00%)

1 (2.08%)

0.327

Heart failure

6 (12.00%)

3 (6.25%)

0.325

  1. Note *P<0.05. MACE: Major adverse cardiac events